Aiforia Technologies Oyj

AIFORIA

FI4000507934

Software

Market Closed - Nasdaq Helsinki Other stock markets 11:23:08 2024-04-29 am EDT			Pre-market 01:32:01 am
3.91 ^EUR	-1.51%		3.93	+0.51%

Apr. 09	Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board	CI
Mar. 07	Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2024

December 04, 2023 at 02:01 am EST

Aiforia Technologies Plc, Company release, December 4, 2023 at 09:00 a.m. EET

The calendar for Aiforia Technologies Plc's financial reporting concerning the financial year 2024 is as follows:

March 7, 2024: Financial Statements Bulletin for financial year 2023
March 13, 2024: The Financial Statements and the Board of Directors' Report for financial year 2023
August 29, 2024: Half-Year Financial Report for 1 January-30 June 2024

Aiforia Technologies's Annual General Meeting will be held on April 4, 2024. The Board of Directors will convene the meeting with a separate company release at a later date.

More information on the events of the financial year will be available on the company's investor pages at https://investors.aiforia.com/investor-calendar.

Further inquiries

Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc, tel. +358405009878 https://investors.aiforia.com/

Certified Adviser

UB Securities Ltd

ubs@unitedbankers.fi

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com

https://news.cision.com/aiforia-technologies-oyj/r/aiforia-technologies-plc-s-financial-reporting-and-annual-general-meeting-in-financial-year-2024,c3886596

https://mb.cision.com/Main/20889/3886596/2468738.pdf

Latest news about Aiforia Technologies Oyj

Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board	Apr. 09	CI
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow	Mar. 06	CI
Aiforia Partners with US Nonprofit to Commercialize AI Predicting Colorectal Cancer Recurrence	Jan. 02	MT
Aiforia Signs a Licensing Agreement with the Mayo Clinic for an AI Model That Improves Prediction of Colorectal Cancer Recurrence	Jan. 02	CI
Aiforia Technologies Enters Three-year Technology Deal with Italian Hospital	Dec. 27	MT
Aiforia Signs A Deal with an Italian Hospital in Catania	Dec. 27	CI
Aiforia Technologies Oyj Announces Appointment of Professor Inti Zlobec to Its Scientific Advisory Board	Dec. 08	CI
Aiforia Technologies plc Appoints Panu Kauppila as Chief Product Officer and A Member of the Management Team	Dec. 01	CI
Aiforia Technologies Plc Initiates Path to Secure its First Regulatory Approval in the United States	23-10-20	CI
Aiforia Technologies Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Aiforia Signs Partnership With Orion for AI-based Image Analysis for Preclinical Research	23-07-05	MT
Aiforia Technologies Oyj Signs A Major Deal with an Italian Regional Health Authority	23-06-29	CI
First NHS Trust Signs Contract to Adopt Aiforia PD-L1 AI Model for Lung Cancer in Clinical Diagnostics	23-04-04	CI
Aiforia Technologies plc Approves Executive Changes	23-03-30	CI
Aiforia Technologies Plc Appoints Manuel Ahlsten as Vice President of Marketing	23-03-10	CI
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-02	CI
Aiforia Technologies Wins AI Diagnostic Services Contract With 25 NHS Hospitals	23-02-10	MT
Aiforia Technologies plc Receives A Contract Award to Provide AI Solutions for 25 NHS Hospitals of the Pathlake Plus Consortium in the UK	23-02-10	CI
Kari Pitkänen, Director of Business Development at Aiforia Technologies Plc, to Retire by the End of December 2022	22-11-24	CI
Aiforia Technologies Oyj Appoints Thomas Westerling-Bui as Chief Commercial Officer of Americas and Member of the Management Team	22-10-14	CI
Aiforia Technologies Plc's Member of the Board of Directors, John Sweeney, Resigns from the Board	22-08-25	CI
Certain Shares of Aiforia Technologies Oyj are subject to a Lock-Up Agreement Ending on 8-JUN-2022.	22-06-07	CI
Aiforia Technologies Launches Aiforia Community Platform	22-04-28	CI
Aiforia Technologies Plc Expands its Portfolio of CE-IVD Marked Clinical Pathology Solutions with New AI Model for Breast Cancer Diagnostics	22-04-20	CI

Chart Aiforia Technologies Oyj

Duration

Period

More charts

Company Profile

Aiforia Technologies Oyj is a Finland-based company providing image analysis software utilizing artificial intelligence (AI). Aiforiaâs business model is based on the development and utilization of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics. The Companyâs cloud-based deep learning artificial intelligence solutions aim to increase the speed, accuracy, and consistency of analyzing medical images across a wide range of fields. Aiforia's solutions aim to automate routine tasks and provide artificial intelligence to support the diagnostic workflow. The product offering consists of Aiforia Create, a solution with which the end user can develop their own AI model for any image analysis application simply by annotating images to train the AI model what to identify, quantify, or measure.

Sector

Software

More about the company

Income Statement Evolution

More financial data

Ratings for Aiforia Technologies Oyj

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.91 EUR

Average target price

4.2 EUR

Spread / Average Target

+7.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
AIFORIA TECHNOLOGIES OYJ	+12.03%	109M
MICROSOFT CORPORATION	+6.97%	2,990B
SYNOPSYS INC.	+5.80%	83.1B
CADENCE DESIGN SYSTEMS, INC.	+3.72%	76.88B
DASSAULT SYSTÈMES SE	-15.18%	52.88B
PALANTIR TECHNOLOGIES INC.	+32.96%	50.84B
ATLASSIAN CORPORATION	-25.56%	46.09B
THE TRADE DESK, INC.	+17.43%	41.3B
SEA LIMITED	+59.31%	37.06B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-10.36%	24.61B

Other Software

Aiforia Technologies Oyj

Equities

AIFORIA

FI4000507934

Software

Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2024

EPS Revisions